Legis Daily

Opioid Prescription Verification Act of 2021

USA117th CongressHR-2355| House 
| Updated: 12/9/2021
Rodney Davis

Rodney Davis

Republican Representative

Illinois

Cosponsors (8)
Doug LaMalfa (Republican)Alexander X. Mooney (Republican)Scott Franklin (Republican)Gus M. Bilirakis (Republican)Ann Wagner (Republican)Michael R. Turner (Republican)Adam Kinzinger (Republican)Ted Budd (Republican)

Health, Education, Labor, and Pensions Committee, Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Opioid Prescription Verification Act of 2021 This bill modifies overdose prevention activities carried out by the Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC). Specifically, HHS must update pharmacist training materials to include information about how to verify the identity of patients who are prescribed medications. In addition, the CDC may give preference, in awarding grants for overdose prevention, to states that maintain a prescription drug monitoring program that mandates the collection of specified information, require prescribers of certain potentially addictive medications to issue prescriptions electronically (subject to some exceptions), and require dispensers of certain potentially addictive medications to enter particular information about the purchase of such medications into their state's prescription drug monitoring program.

Bill Text Versions

View Text
4 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-4810
Opioid Prescription Verification Act of 2019
Apr 5, 2021
Introduced in House
Apr 5, 2021
Referred to the House Committee on Energy and Commerce.
Apr 13, 2021
Referred to the Subcommittee on Health.
Jul 15, 2021
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Jul 15, 2021
Subcommittee Consideration and Mark-up Session Held.
Jul 21, 2021
Ordered to be Reported (Amended) by Voice Vote.
Jul 21, 2021
Committee Consideration and Mark-up Session Held.
Nov 30, 2021
Placed on the Union Calendar, Calendar No. 130.
Nov 30, 2021
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-180.
Nov 30, 2021
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
Nov 30, 2021
Considered under suspension of the rules. (consideration: CR H6691-6693; text: CR H6691)
Nov 30, 2021
DEBATE - The House proceeded with forty minutes of debate on H.R. 2355.
Nov 30, 2021
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Dec 9, 2021
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 410 - 15 (Roll no. 422). (consideration: CR H7540-7541)
View Vote
Dec 9, 2021
Motion to reconsider laid on the table Agreed to without objection.
Dec 9, 2021
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • Bill from Previous Congress

    HR 116-4810
    Opioid Prescription Verification Act of 2019


  • April 5, 2021
    Introduced in House


  • April 5, 2021
    Referred to the House Committee on Energy and Commerce.


  • April 13, 2021
    Referred to the Subcommittee on Health.


  • July 15, 2021
    Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .


  • July 15, 2021
    Subcommittee Consideration and Mark-up Session Held.


  • July 21, 2021
    Ordered to be Reported (Amended) by Voice Vote.


  • July 21, 2021
    Committee Consideration and Mark-up Session Held.


  • November 30, 2021
    Placed on the Union Calendar, Calendar No. 130.


  • November 30, 2021
    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-180.


  • November 30, 2021
    Mr. Pallone moved to suspend the rules and pass the bill, as amended.


  • November 30, 2021
    Considered under suspension of the rules. (consideration: CR H6691-6693; text: CR H6691)


  • November 30, 2021
    DEBATE - The House proceeded with forty minutes of debate on H.R. 2355.


  • November 30, 2021
    At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.


  • December 9, 2021
    On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 410 - 15 (Roll no. 422). (consideration: CR H7540-7541)
    View Vote


  • December 9, 2021
    Motion to reconsider laid on the table Agreed to without objection.


  • December 9, 2021
    Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Health

Business recordsDrug, alcohol, tobacco useDrug trafficking and controlled substancesGovernment information and archivesHealth information and medical recordsHealth personnelHealth programs administration and fundingPhotography and imagingPrescription drugsRetail and wholesale trades

Opioid Prescription Verification Act of 2021

USA117th CongressHR-2355| House 
| Updated: 12/9/2021
Opioid Prescription Verification Act of 2021 This bill modifies overdose prevention activities carried out by the Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC). Specifically, HHS must update pharmacist training materials to include information about how to verify the identity of patients who are prescribed medications. In addition, the CDC may give preference, in awarding grants for overdose prevention, to states that maintain a prescription drug monitoring program that mandates the collection of specified information, require prescribers of certain potentially addictive medications to issue prescriptions electronically (subject to some exceptions), and require dispensers of certain potentially addictive medications to enter particular information about the purchase of such medications into their state's prescription drug monitoring program.

Bill Text Versions

View Text
4 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-4810
Opioid Prescription Verification Act of 2019
Apr 5, 2021
Introduced in House
Apr 5, 2021
Referred to the House Committee on Energy and Commerce.
Apr 13, 2021
Referred to the Subcommittee on Health.
Jul 15, 2021
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Jul 15, 2021
Subcommittee Consideration and Mark-up Session Held.
Jul 21, 2021
Ordered to be Reported (Amended) by Voice Vote.
Jul 21, 2021
Committee Consideration and Mark-up Session Held.
Nov 30, 2021
Placed on the Union Calendar, Calendar No. 130.
Nov 30, 2021
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-180.
Nov 30, 2021
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
Nov 30, 2021
Considered under suspension of the rules. (consideration: CR H6691-6693; text: CR H6691)
Nov 30, 2021
DEBATE - The House proceeded with forty minutes of debate on H.R. 2355.
Nov 30, 2021
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Dec 9, 2021
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 410 - 15 (Roll no. 422). (consideration: CR H7540-7541)
View Vote
Dec 9, 2021
Motion to reconsider laid on the table Agreed to without objection.
Dec 9, 2021
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • Bill from Previous Congress

    HR 116-4810
    Opioid Prescription Verification Act of 2019


  • April 5, 2021
    Introduced in House


  • April 5, 2021
    Referred to the House Committee on Energy and Commerce.


  • April 13, 2021
    Referred to the Subcommittee on Health.


  • July 15, 2021
    Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .


  • July 15, 2021
    Subcommittee Consideration and Mark-up Session Held.


  • July 21, 2021
    Ordered to be Reported (Amended) by Voice Vote.


  • July 21, 2021
    Committee Consideration and Mark-up Session Held.


  • November 30, 2021
    Placed on the Union Calendar, Calendar No. 130.


  • November 30, 2021
    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-180.


  • November 30, 2021
    Mr. Pallone moved to suspend the rules and pass the bill, as amended.


  • November 30, 2021
    Considered under suspension of the rules. (consideration: CR H6691-6693; text: CR H6691)


  • November 30, 2021
    DEBATE - The House proceeded with forty minutes of debate on H.R. 2355.


  • November 30, 2021
    At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.


  • December 9, 2021
    On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 410 - 15 (Roll no. 422). (consideration: CR H7540-7541)
    View Vote


  • December 9, 2021
    Motion to reconsider laid on the table Agreed to without objection.


  • December 9, 2021
    Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Rodney Davis

Rodney Davis

Republican Representative

Illinois

Cosponsors (8)
Doug LaMalfa (Republican)Alexander X. Mooney (Republican)Scott Franklin (Republican)Gus M. Bilirakis (Republican)Ann Wagner (Republican)Michael R. Turner (Republican)Adam Kinzinger (Republican)Ted Budd (Republican)

Health, Education, Labor, and Pensions Committee, Health Subcommittee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Business recordsDrug, alcohol, tobacco useDrug trafficking and controlled substancesGovernment information and archivesHealth information and medical recordsHealth personnelHealth programs administration and fundingPhotography and imagingPrescription drugsRetail and wholesale trades